Inactivation of Necroptosis-Promoting Protein MLKL Creates a Therapeutic Vulnerability in Colorectal Cancer Cells

Scientists found unexpectedly that MLKL gene knockout enhanced colorectal cancer cell death caused by a protein synthesis inhibitor homoharringtonine used for chronic myeloid leukemia treatment.